Prevalence of Human Papillomavirus Infection and its Association with the Risk of Cervical Cancer among Hiv-Positive Women in Plateau State, North-Central Nigeria
DOI:
https://doi.org/10.47430/ujmr.2491.016Keywords:
Cervical cancer, HIV, CD4, Viral load, Pap SmearAbstract
Study’s Novelty/Excerpt
- This study investigates the prevalence and risk factors of HPV among HIV-infected women in Plateau State, Nigeria, highlighting a significant correlation between low CD4+ counts, high viral loads, and increased HPV infection rates.
- By utilizing comprehensive diagnostic methods including ELISA for HPV detection and cytology for cervical abnormalities, the research offers robust data linking immunosuppression and HPV-related cervical pathology in a high-risk population.
- The findings emphasize the urgent need for targeted interventions to improve sexual health behaviors and further research on how low immunity accelerates cervical cancer progression in both HIV-positive women and the broader population.
Full Abstract
Human papillomavirus (HPV) is one of the most common sexually transmitted infections (STI) associated with cervical, uterine, and anogenital cancers. Persistent infection with HPV is associated with abnormal cervical cells, which can develop into cervical cancer if left untreated. Human papillomaviruses are the first viruses to have been acknowledged to prompt carcinogenesis, and they are linked with cancers of the uterine cervix, anogenital tumours, and head and neck malignancies. A hospital-based study of HIV-infected women across the three senatorial zones of Plateau State, Nigeria, was conducted between November 2018 to November 2020. Ethical approval for the study was first obtained from the ethical committee of Plateau State Specialist Hospital Jos, and informed consent to participate in the research was also obtained from each participant. HIV status confirmation was first done through standard rapid test procedures, followed by cytology testing via the Pap smear procedure to detect any precancerous or malignant changes in the cervix. Subsequent detection of HPV utilized the ELISA procedure, while CD4+ cell count and viral load estimations were done using flow cytometry and nucleic acid amplification techniques, respectively. Questionnaires were administered to obtain information on cervical cancer risk factors and clinical presentations. The overall prevalence of HPV was 28% among HIV-infected women. More HPV infection (31.9%) occurred in women with low CD4+ count (0-200 cells/mm3), and also highest (50.0%) among women with the highest HIV viral load (>100 copies/mL). The possible risk factors identified in this study include multiple sexual partnering, low condom usage, and coinfection with other STIs, among others. In conclusion, this study identified a high HPV prevalence, low CD4+ counts, and coinfection with other STIs among high-risk populations (HIV-infected women). We, therefore, recommend improved sexual behaviours and further research on the impact of low immunity on the rate of progression of cervical abnormality to cervical cancer, not just in HIV-positive women but in the general population.
Downloads
References
Ajang, A.Y., Elijah, E.E., Jatau, E.D., Aminu, M. and Longwap, A.S. (2021). Serologic Evidence of High-Risk Human Papillomavirus 16 and 18 Infections and Risk of Prostate Cancer in Northwestern Nigeria. Journal of Medical Science and Clinical Research, 9(4):130-139.
Alex, F., Francois, C., Eduardo, F., and Catherine, H. (2003). Human Papillomavirus and HIV Co-infection and the Risk of Neoplasia of the Lower Genital Track: A Review of Recent Developments. Canadian Medical Association Journal, 169(5): 431-434.
Aminu, M., Gwafan, J.Z., Inabo, H.I., Oguntayo, A.O., Ella, E.E. and Koledade, A.K. (2014). Seroprevalence of Human Papillomavirus Immunoglobulin G Antibodies among Women Presenting at the Reproductive Health Clinic of a University Teaching Hospital in Nigeria. International Journal of Women’s Health,6:479-487. https://doi.org/10.2147/IJWH.S56388
Beyazit, F., Silan, F., Gencer, M., Aydin, B., Paksoy, B., Unsal, M. and Ozdemir, O. (2018). The Prevalence of HPV Genotypes Detected by PCR in Women with Normal and Abnormal Cervico-vaginal cytology. Gynecology, 89(2):62-67. PMID: 29512809. https://doi.org/10.5603/GP.a2018.0011.
Blackman, E., Thurman, N., Halliday, D., Butler, R., Francis, D., Joseph, M., Thomoson, J., Akers, A., Andraos-Selim, C., Bondzi, C., Taioli, E., Hagan, K., Jones, E., Jones, J., Moss, C., Smith, A., Ashing K. and Ragin, C. (2013). Mlticenter Study of HPV and the HPV Vaccine: Knowledge and Attitudes Among People of African Descent. Infectious Diseases in Obstetrics and Gynecology, 2013:1-8. https://doi.org/10.1155/2013/428582. PMID: 23956612.
Cambrea, S., Aschie, M., Resul, G., Mitroi, A., Chisoi, A., Nicolau, A., Baltatescu, G., Cretu, A., Lupasteanu, G., Serbanescu, L., Manea, M., Topliceanu, S., Petcu, L., Pazara, L. and Cozaru, G. (2022). HPV and HIV Coinfection in Women from a Southeast Region of Romania-PICOPIV Study. Medicina, 58(6): 760.
Chinaka, C.C. and Nwazue, U.C. (2013). Awarencess of Cervical Cancer and its Screening in Abakalili, Nigeria. African Journal of Cellular Pathalogy, 1(1): 47-51. https://doi.org/10.1177/0340035219861400.
Davies, J.K. and Thomas, I. (2001). Current Methods of Testing for Human Papillomavirus, Best Practice & Research. Clinical Obstetrics & Gynaecology,15(5): 677-700. https://doi.org/10.1053/beog.2001.0214.
De Vuyst, H., Mugo, N.R., Chung, M.H., McKenzie, K.P., Nyongesa-Malava, E., Tenet, V., Njoroge, J.W., Sakr, S.R., Meijer, C.M., Snijders, P.J., Rana, F.S. and Franceschi, S. (2012). Prevalence and Determinants of Human Papillomavirus Infection and Cervical Lesions in HIV-positive Women in Kenya. British Journal of Cancer, 107(9):1624-30. https://doi.org/10.1038/bjc.2012.441. PMID: 23033006.
Franceschi, S., Raza, S.A., , Pallardy, S., Malik, F.R., Avan, B.I., Zafar, A., Ali, S.H., Pervez, S., Serajuddaula, S., Snijders, P.J., van Kemenade, F.J., Meijer, C.J., Shershah, S. and Clifford, G.M. (2010). Human Papillomavirus Infection in Women with and without Cervical Cancer in Karachi, Pakistan. British Journal of Cancer, 102(11):1657-60. https://doi.org/10.1038/sj.bjc.6605664. PMID: 20407442; PMCID: PMC2883157.
García-Espinosa, B., Nieto-Bona, M., Rueda, S. (2009). Genotype Distribution of Cervical Human Papillomavirus DNA in Women with Cervical Lesions in Bioko, Equatorial Guinea. Diagnostic Pathology, 4, 31:76-83. https://doi.org/10.1186/1746-1596-4-31
Gautam, A., Chakravarty, J., Singh, V.K., Ghosh, A., Chauhan, S.B., Rai, M. and Sundar, S. (2018). Human Papillomavirus Infection & Anal Cytological Abnormalities in HIV-positive Men in Eastern India. BMC Infectious Disease, 18(1):692-695. https://doi.org/10.1186/s12879-018-3618-3. PMID: 30587145; PMCID:
Hayatudeen, M.R., Abdulkadir, B., Mukhtar, A. and Aminu, M. (2021). Cytological Screening and Seroincidence of IgM with Possible Risk Factors Associated with Naturally Selected High-risk Group for Oncogenic Human Papillomavirus Infection in Daura, Katsina State. Dutse Journal of Pure and Applied Sciences, 7(3): 73-81.https://doi.org/10.4314/dujopas.v7i3b.8
ICO/IARC Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers. Factsheet 2023. www.who.int/ HPV Centre (accessed on 29 March, 2023).
Krashias, G., Kpotides, D. and Christodoulou (2017). HPV Prevalence and Type Distribution in Cypriot Women with Cervical Cytological Abnormalities. BMC Infectious Diseases, 17(346): 2-10. https://doi.org/10.1186/s12879-017-2439-0
Leonard, S.M., Wenbin, W., Stuart, I., Collins, M.P., Afaf, D., Christothea, C.W., Lawrence, S.Y., Sally, R., C. and Woodman, O. (2022). Human Papillomavirus Imposes an Instructive Pattern of DNA Methylation Changes which Parallel the Natural History of Cervical HPV Infection in Young Women. Carcinogenesis, 33(7):1286–1293. https://doi.org/10.1093/carcin/bgs157
Mendoza-Pinto, C., García-Carrasco, M., Vallejo-Ruiz, V. (2017). Incidence of Cervical Human Papillomavirus Infection in Systemic Lupus Erythematosus Women. Lupus, 26(9): 944-951. https://doi.org/10.1177/0961203316686708
Mikoff, H., Zhong, Y., Burk, R.D., Pelefsky, J.N., Xue, X., Watts, D.H., Levine, A.M., Wright, R.L., Colie, C., Souza, G.D., Massad, L.S. and Strickler, H.D. (2010). Influence of Adherent and Effective Antiretroviral Therapy Use on Human Papillomavirus Infection and Aquamous Intraepithelial Lesions In HIV-Positive Women. Journal of Infectious Diseases, 201:681-690. PMID: 20105077; PMCID: PMC2818607. https://doi.org/10.1086/650467.
Minkoff, H., Zhong, Y., Burk, R.D., Palefsky, J.M., Xue, X., Watts, D.H., Levine, A.M., Wright, R.L., Colie, C., D'Souza, G., Massad, L.S. and Strickler, H.D. (2010). Influence of Adherent and Effective Antiretroviral Therapy Use on Human Papillomavirus Infection and Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-positive Women. Journal of Infectious Disease, 201(5):681-90. https://doi.org/10.1086/650467. PMID: 20105077; PMCID: PMC2818607.
Monteiro, J.C., Fonseca, R.B., Ferreira, T.C., Rodrigues, L.L., Silva, A.R., Gomes, S.T., Silvestre, R.V., Gomes, S.T., Silva, A.N., Pamplona, I., Vallinoto, A.C., Ishak, R. and Machado, L.F. (2021). Prevalence of High-risk HPV in HIV-infected Women from Belem, Para, Amazon Region of Brazil: A Cross-Sectional Study. Frontiers in Public Health, 9(6): 1-8. https://doi.org/10.3389/fpubh.2021.649152.
Musa, J., Achenbach, C., Taiwo, C. and Berzins, B. (2014). High-risk human papillomavirus and cervical abnormalities in HIV-infected women with normal cervical cytology. Infectious Agents and Cancer, 9:36. https://doi.org/10.1186/1750-9378-9.
Naing, L., Winn, T. and Rusli, B.N. (2006) Practical Issues in Calculating the Sample Size for Prevalence Studies. Medical Statistics. Archives of Orofacial Sciences, 1, 9-14. https://www.scribd.com/doc/63105077/How-to-Calculate-Sample-Size.
Nowak, R., Gravitt, P., He, X., Ketende, S., Anom, W., Omuh. H., Blattner, W. and Charurat, M. (2017). Prevalence of Anal High-Risk Human Papillomavirus Infections among HIV-positive and HIV-negative Men who have Sex with Men (MSM) in Nigeria. Pubmed Central, 43(4): 243-248.
Okunade, K.S. (2020). Human Papillomavirus and Cervical Cancer. Journal of Obstetrics and Gynecology, 40(5): 602-608. https://doi.org/10.5772/intechopen.81581.
Paramsothy, P., Jamieson, D., Heilig, C., Schuman, P., Robert, S., Keerti, V., Rompalo, A., Susan, M.D. and Duerr, Ann. (2009). The Effect of Highly Active Antiretroviral Therapy on Human Papillomavirus Clearance and Cervical Cytology. Obstetrics & Gynecology, 113(1):26-31. https://doi.org/10.1097/AOG.0b013e31819225cb. PMID: 19104356.
Pinto, R.A., Martins, L.F.L., Moreira, M.Â.M., Reis, N.B.D., Felix, S.P., Vidal, J.P., Torres, L.C., Souza, A.I. and Almeida, L.M. (2011). Human Papillomavirus 16 Lineage D is Associated with High Risk of Cervical Cancer in the Brazilian Northeast Region. Revised Brazilian Gynecology Obstetrics, 45(8): 74-79. https://doi:10.1055/s-0043-1772180.
Sagay, A.S., Imade, G.E., Onwuliri, V., Egah, D.Z., Grigg, M.J., Musa, J., Thacher, T.D., Adisa, J.O., Potts, M. and Short, R.V. (2020). “Genital Tract Abnormalities among Female Sex Workers who Douche with Lemon/Lime Juice in Nigeria.” African Journal of Reproductive Health, 13(1): 37-45.
Sarkar, K., Pal, R. and Bal, B. (2011). Oncogenic HPV among HIV-infected Female Population in West Bengal, India. BMC Infectious Disease, 11(72): 65-72. https://doi.org/10.1186/1471-2334-11-72
Seagar, A.L., Cubie, H.A., Beattie, G.J., Monaghan, S. and Williams, A.R. (2000). A Longitudinal Study of HPV Detection and Cervical Pathology in HIV-infected Women. Sexually Transmitted Infections, 76: 257-261.
Shrestha, S., Sudenga, S.L., Smith, J.S., Bachman, L.H, Wilson, C.M. and Mirjam, C.K. (2010). The Impact of Highly Active Antiretroviral Therapy on Prevalence and Incidence of Cervical Human Papillomavirus Infection In HIV-Positive Adolescents. Biomed Central Infections Disease, 10:295. PMID: 20946655; PMCID: PMC2965148. https://doi.org/10.1186/1471-2334-10-295.
Silva, L., Miranda, A., Batalha, R., Ferreira, L., Santos, M. and Talhari, S. (2015). High-Risk Human Papillomavirus and Cervical Lesions among Women living with HIV/AIDS in Brazilian Amazon, Brazil. The Brazilian Journal of Infectious Diseases, 19(6): 557-562. https://doi.org/10.1016/j.bjid.2015.07.001.
Song, D., Li, H. and Dai, J. (2015). Effect of Human Papillomavirus Infection on the Immune System and Its Role in the Course of Cervical Cancer (review). Oncology Letters, 10:600-606.
Sule A.A. and Ochichia, O. (2017). A Histologic Review of Cervical Cancer in Kano, Nigeria. Sahel Medical Journal, 20:16-20.
Temesgen, M. M., Alemu, T., Shiferaw, B., Legesse, S., Zeru, T., Haile, M., and Gelanew, T. (2021). Prevalence of Oncogenic Human Papillomavirus (HPV 16/18) Infection, Cervical Lesions and its Associated Factors among Women Aged 21–49 Years in Amhara Region, Northern Ethiopia. PLOS ONE, 16(3): 48-49. https://doi.org/10.1371/journal.pone.0248949
Tulay, P. and Serakinci, N., (2016). The Role of Human Papillomaviruses in Cancer Progression. Journal of Cancer Metastasis and Treatment, 2:201-213. http://dx.doi.org/10.20517/2394-4722.2015.67.
Wang, X., Huang, X. and Zhang, Y. (2018). Involvement of Human Papillomaviruses in Cervical Cancer. Frontiers in Microbiology, 9:2896. PMID: 30546351; PMCID: PMC6279876. https://doi.org/10.3389/fmicb.2018.02896.
World Health Organization (2011). Cancer in Africa. A Guide to Essential Practice. Geneva: World Health Organization. Accessed June2023. http://www.who.int/mediacentre/factsheets/fs/187/en.
World Health Organization (2019). Global Burden of Cervical Cancer report in 2019. Global Report. Geneva: World Health Organization. Accessed February2024. http://www.who.int/mediacentre/factsheets/fs/806/en.
Yousif, M.G., Al-Amran, F.G. and Yousif, N.G. (2023). Prevalence and Associated Factors of Human Papillomavirus Infection Among -Iraqi Women. Medical Advances and Innovations Journal, 1(1):1-10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yakubu Abubakar, A Y Ajang, E E Ella, A O Oguntayo, M Aminu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
